Market Cap 1.08B
Revenue (ttm) 28.83M
Net Income (ttm) -162.86M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -564.90%
Debt to Equity Ratio 0.00
Volume 3,783,300
Avg Vol 4,398,448
Day's Range N/A - N/A
Shares Out 299.34M
Stochastic %K 52%
Beta 0.73
Analysts Strong Sell
Price Target $9.00

Company Profile

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its product pipeline includes ABCL635, an antibody-drug candidate, which is in preclinical trial to treat metabolic and endocrine conditions; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in preclinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a research coll...

Industry: Biotechnology
Sector: Healthcare
Phone: 604 559 9005
Address:
150 West 4th Ave, Vancouver, Canada
WOLFSTREET
WOLFSTREET Dec. 21 at 7:42 PM
$ABCL $PYPL $SNAP $LMND $OSCR Cute Story. I use CC9.4 and stay 100% invested 24/7. If you are sitting on CASH, you just do not know where to put it, and I'm not talking about CASH you need to buy a ring camera with, I'm talking about positioning CASH.
0 · Reply
StockAnalyst_SA
StockAnalyst_SA Dec. 21 at 6:53 PM
Portfolio Update – December 21st, 2025 The year is winding down and Christmas is coming up next week, so I wanted to share a quick portfolio update. I sold $ABCL this week to free up some cash and redeployed part of that into $PYPL. One question I get a lot is about my cash levels. Right now, I’m sitting at ~20% cash, which is high for me. There are two reasons for that: - I’m saving for a ring and hoping to propose to my girlfriend of 5 years in 2026 - I want cash ready in case of a market pullback or new opportunities Even with the higher cash position, I still feel very good about how my portfolio is positioned. In my other portfolio, I added $SNAP as a new position, which now sits alongside $LMND and $OSCR as higher-upside plays. Get more information! It's free 👉 @StockAnalyst_SA
0 · Reply
tradersunion353
tradersunion353 Dec. 21 at 4:19 PM
$ABCL To those who’ve held this for over a year, do you think 2026 could be the comeback year, maybe even back to $10
1 · Reply
1iquid
1iquid Dec. 21 at 2:57 PM
💎 Liquid® Live Actionable Trade Asset: $ABCL Contracts: $ABCL January 15, 2027 $4 Calls Scale in: $1.35- $1.66 Scale out: $5.27-$9.03 Profit Potential : 194% ROI Blended Join 💎 Here: https://1iquid.com
0 · Reply
Thelonius_Stonk
Thelonius_Stonk Dec. 21 at 12:18 PM
$ABCL flip resist to support would be pretty. otherwise back to mid 2s
1 · Reply
economist9
economist9 Dec. 21 at 2:32 AM
Dr. Quake owns 1,100,436 shares or $ABCL. Always nice to see directors share the gain and pain with fellow shareholders.Unlock more for free👉@economist9
0 · Reply
StockAnalyst_SA
StockAnalyst_SA Dec. 20 at 8:15 PM
Someone shared this chart. Look at that volume shelf. New uptrend. Deep pullback into support. Multi year downtrend breakout. One of the best narratives for 2026: AI + biotech. Elite team and board. No dilution, lots of cash. R/R is insane : fundamentals + chart. $ABCL
0 · Reply
StockAnalyst_SA
StockAnalyst_SA Dec. 20 at 7:54 PM
$ABCL trades near cash value despite a world-class antibody platform and Phase 1 programs dosing now. $700M+ liquidity, no dilution, strong government backing, and 103+ partnerships create massive optionality. Phase 1 leads target hot flashes and atopic dermatitis with infrequent dosing. IP validated via Bruker settlement. Pipeline, manufacturing, and royalties essentially free. Any positive readout or milestone could trigger a major rerate—asymmetric upside, limited downside. Get more information! It's free 👉 @StockAnalyst_SA
1 · Reply
estatebuyersmia
estatebuyersmia Dec. 19 at 10:29 PM
$ABCL ED_NG... WATCH $PRME... ABOUT TO EXPLODE....
0 · Reply
Stocktradesmoon
Stocktradesmoon Dec. 19 at 10:12 PM
0 · Reply
Latest News on ABCL
AbCellera Appoints Dr. Stephen Quake to its Board of Directors

Nov 10, 2025, 9:00 AM EST - 5 weeks ago

AbCellera Appoints Dr. Stephen Quake to its Board of Directors


AbCellera Reports Q3 2025 Business Results

Nov 6, 2025, 4:05 PM EST - 6 weeks ago

AbCellera Reports Q3 2025 Business Results


AbCellera Biologics: Entering Growth Phase After A Pause

Oct 6, 2025, 7:35 AM EDT - 2 months ago

AbCellera Biologics: Entering Growth Phase After A Pause


AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer

Sep 10, 2025, 9:07 AM EDT - 3 months ago

AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer


AbCellera Biologics Inc. (ABCL) Q1 2025 Earnings Call Transcript

May 8, 2025, 10:33 PM EDT - 8 months ago

AbCellera Biologics Inc. (ABCL) Q1 2025 Earnings Call Transcript


AbCellera Reports Q1 2025 Business Results

May 8, 2025, 4:05 PM EDT - 8 months ago

AbCellera Reports Q1 2025 Business Results


AbCellera Biologics Inc. (ABCL) Q4 2024 Earnings Call Transcript

Feb 27, 2025, 11:26 PM EST - 10 months ago

AbCellera Biologics Inc. (ABCL) Q4 2024 Earnings Call Transcript


AbCellera Reports Full Year 2024 Business Results

Feb 27, 2025, 4:05 PM EST - 10 months ago

AbCellera Reports Full Year 2024 Business Results


AbCellera to Participate at Upcoming Investor Conferences in March

Feb 11, 2025, 4:05 PM EST - 11 months ago

AbCellera to Participate at Upcoming Investor Conferences in March


AbCellera Biologics: Still A Concept Stock

Dec 23, 2024, 4:39 PM EST - 1 year ago

AbCellera Biologics: Still A Concept Stock


AbCellera Reports Q3 2024 Business Results

Nov 4, 2024, 4:05 PM EST - 1 year ago

AbCellera Reports Q3 2024 Business Results


AbCellera: A Platform To Pipeline Transition

Oct 14, 2024, 12:04 PM EDT - 1 year ago

AbCellera: A Platform To Pipeline Transition


AbCellera: A Waiting Game With High Uncertainty

Aug 23, 2024, 4:43 AM EDT - 1 year ago

AbCellera: A Waiting Game With High Uncertainty


AbCellera Reports Q2 2024 Business Results

Aug 6, 2024, 4:05 PM EDT - 1 year ago

AbCellera Reports Q2 2024 Business Results


AbCellera Reports Q1 2024 Business Results

May 7, 2024, 4:05 PM EDT - 1 year ago

AbCellera Reports Q1 2024 Business Results


WOLFSTREET
WOLFSTREET Dec. 21 at 7:42 PM
$ABCL $PYPL $SNAP $LMND $OSCR Cute Story. I use CC9.4 and stay 100% invested 24/7. If you are sitting on CASH, you just do not know where to put it, and I'm not talking about CASH you need to buy a ring camera with, I'm talking about positioning CASH.
0 · Reply
StockAnalyst_SA
StockAnalyst_SA Dec. 21 at 6:53 PM
Portfolio Update – December 21st, 2025 The year is winding down and Christmas is coming up next week, so I wanted to share a quick portfolio update. I sold $ABCL this week to free up some cash and redeployed part of that into $PYPL. One question I get a lot is about my cash levels. Right now, I’m sitting at ~20% cash, which is high for me. There are two reasons for that: - I’m saving for a ring and hoping to propose to my girlfriend of 5 years in 2026 - I want cash ready in case of a market pullback or new opportunities Even with the higher cash position, I still feel very good about how my portfolio is positioned. In my other portfolio, I added $SNAP as a new position, which now sits alongside $LMND and $OSCR as higher-upside plays. Get more information! It's free 👉 @StockAnalyst_SA
0 · Reply
tradersunion353
tradersunion353 Dec. 21 at 4:19 PM
$ABCL To those who’ve held this for over a year, do you think 2026 could be the comeback year, maybe even back to $10
1 · Reply
1iquid
1iquid Dec. 21 at 2:57 PM
💎 Liquid® Live Actionable Trade Asset: $ABCL Contracts: $ABCL January 15, 2027 $4 Calls Scale in: $1.35- $1.66 Scale out: $5.27-$9.03 Profit Potential : 194% ROI Blended Join 💎 Here: https://1iquid.com
0 · Reply
Thelonius_Stonk
Thelonius_Stonk Dec. 21 at 12:18 PM
$ABCL flip resist to support would be pretty. otherwise back to mid 2s
1 · Reply
economist9
economist9 Dec. 21 at 2:32 AM
Dr. Quake owns 1,100,436 shares or $ABCL. Always nice to see directors share the gain and pain with fellow shareholders.Unlock more for free👉@economist9
0 · Reply
StockAnalyst_SA
StockAnalyst_SA Dec. 20 at 8:15 PM
Someone shared this chart. Look at that volume shelf. New uptrend. Deep pullback into support. Multi year downtrend breakout. One of the best narratives for 2026: AI + biotech. Elite team and board. No dilution, lots of cash. R/R is insane : fundamentals + chart. $ABCL
0 · Reply
StockAnalyst_SA
StockAnalyst_SA Dec. 20 at 7:54 PM
$ABCL trades near cash value despite a world-class antibody platform and Phase 1 programs dosing now. $700M+ liquidity, no dilution, strong government backing, and 103+ partnerships create massive optionality. Phase 1 leads target hot flashes and atopic dermatitis with infrequent dosing. IP validated via Bruker settlement. Pipeline, manufacturing, and royalties essentially free. Any positive readout or milestone could trigger a major rerate—asymmetric upside, limited downside. Get more information! It's free 👉 @StockAnalyst_SA
1 · Reply
estatebuyersmia
estatebuyersmia Dec. 19 at 10:29 PM
$ABCL ED_NG... WATCH $PRME... ABOUT TO EXPLODE....
0 · Reply
Stocktradesmoon
Stocktradesmoon Dec. 19 at 10:12 PM
0 · Reply
Ed_Ng
Ed_Ng Dec. 19 at 9:08 PM
$ABCL huge outflow after hours. They are trying to exit. We can call exit scam!
0 · Reply
SimpleWinningSetups
SimpleWinningSetups Dec. 19 at 8:13 PM
Hedge Alert Live - Protect Your Portfolio Contract: $ABCL $3.00 Put · JAN 16, 2026 Exp Entry Price: $0.12 - $0.13 Exit Price Target: $0.25 Profit Margin: +107% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
MrResurge
MrResurge Dec. 19 at 7:52 PM
ARBB is breaking out right now!! What is happening to ARBB 🤯 This could turn into the craziest runner of the day. Bulls need to keep ARBB on watch immediately. ARBB has only 500k share public float remianing! Also watching $ABCL $FBIO $SNDX $TGTX -+
1 · Reply
hagarone
hagarone Dec. 19 at 6:49 PM
0 · Reply
BrokeStudentProblems
BrokeStudentProblems Dec. 19 at 5:55 PM
Phenomenal deep dive on $ABCL for those that missed it https://northwiseproject.com/abcl-stock-analysis/
0 · Reply
estatebuyersmia
estatebuyersmia Dec. 19 at 5:08 PM
$ABCL https://www.statnews.com/2025/12/18/biotech-growing-up-is-turning-profitable/
0 · Reply
Ed_Ng
Ed_Ng Dec. 19 at 3:32 PM
$ABCL scam is scam. Period
2 · Reply
Hognose
Hognose Dec. 19 at 2:39 PM
$FOLD I called Fold, next $CPRX $ABCL $ASND
0 · Reply
yuuuuuung
yuuuuuung Dec. 19 at 11:26 AM
$ABCL forecast are good, firm is good, CEO is good. higher
0 · Reply
Yuuuuuuung
Yuuuuuuung Dec. 19 at 8:50 AM
$ABCL this is a great moment to position yourself !
0 · Reply
Stocktradesmoon
Stocktradesmoon Dec. 19 at 6:12 AM
$ABCL Looking at way out of money call options for $ABCL
1 · Reply
JustTheFactsInvesting
JustTheFactsInvesting Dec. 19 at 6:07 AM
0 · Reply